Low dose PUFA
OtherLow dose PUFA
NCT Number: NCT03192839
This clinical trial will evaluate the effects of giving supplements of PUFA to premature infants.
Looking for future studies?
Notify MeUp to 3 day
All sexes
Interventional
Not applicable
Rush University Medical Center, Chicago, Illinois, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Low dose PUFA
High dose PUFA
Placebo
Time frame: 2 weeks of age
Time frame: 8 weeks of age
Time frame: 8 weeks
Full enteral feed of 120 kcal/kg/day
Time frame: 8 weeks
Time frame: 8 weeks
Mead Johnson Nutrition
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07689669
Apnea, Apnea of Prematurity
Konya, Turkey (Türkiye)
View Trial DetailsNCT07622459
Female Urogenital Diseases and Pregnancy Complications, Mechanical Ventilation
Sanliurfa, Turkey (Türkiye)
View Trial DetailsNCT07577180
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Köseköy, Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT07494123
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Cairo, Cairo Governorate, Egypt
View Trial Details